EXTEND BIOSCIENCES INC

Newton, United States · Founded 2015 · $13.7M raised

Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$13.7M
Last Round
GrantSep 2024
Rounds
10

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Extend Biosciences is a clinical-stage biotechnology company that develops protein and peptide therapeutics with extended half-lives using its proprietary D-VITylation technology platform, which attaches a small vitamin D-based molecule to protect conjugated peptides and proteins from renal clearance. The company has received 10 SBIR/STTR awards from HHS, the Department of Defense, and the National Science Foundation, and its lead candidate EXT608 has completed Phase 1 trials with FDA grant funding supporting Phase 2a trials targeting rare diseases.

Summary

EXTEND BIOSCIENCES INC is a Biotech company based in Newton, United States, founded in 2015. It has raised $13.7M in total across 10 rounds, most recently a Grant round in Sep 2024. Investors include MassVentures.

Funding History

GrantSBIR Phase II (NIH)Sep 2024
$2.0M

Sign up to see all 10 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EXTEND BIOSCIENCES INC on Indexed.vc
<a href="https://indexed.vc/companies/extend-biosciences-inc"><img src="https://indexed.vc/api/badge/company/extend-biosciences-inc" alt="EXTEND BIOSCIENCES INC on Indexed.vc" width="260" height="76" /></a>